{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T02:12:12Z","timestamp":1792548732949,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":97,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Bromelain is a proteolytic enzyme complex naturally found in the stem, fruit, and juice of pineapple, while papain is a proteolytic enzyme derived from the latex of the papaya plant. These bioactive components have attracted increasing scientific interest due to their reported roles in cell proliferation and wound healing, suppression of oxidative stress through free radical scavenging, and apoptosis-related pathways. Although bromelain and papain have been associated with various health-related effects, their effects on healthy cells remain largely unexplored. In this study, different concentrations of Kiperin Bromelain &amp; Papain (KBP) (1.0\u20133.5\u00a0\u00b5g\/mL) were tested in healthy cell lines. Based on the concentration showing the highest cell viability, 2.5\u00a0\u00b5g\/mL was selected for further analyses, and CCD-18Co (colon fibroblasts), HME-1 (mammary epithelial cells), and HaCaT (keratinocytes) were treated accordingly. Cell viability was assessed by cell counting, and wound healing was evaluated. Gene expression levels of\n                    <jats:italic>MMP9<\/jats:italic>\n                    ,\n                    <jats:italic>IVL<\/jats:italic>\n                    ,\n                    <jats:italic>FLG<\/jats:italic>\n                    ,\n                    <jats:italic>IL-6<\/jats:italic>\n                    ,\n                    <jats:italic>IL-10<\/jats:italic>\n                    ,\n                    <jats:italic>NFK\u03b2<\/jats:italic>\n                    , and\n                    <jats:italic>TNF-\u03b1<\/jats:italic>\n                    were measured by real-time PCR. KBP exposure increased cell viability in all cell lines, with the most pronounced effect observed at 2.5\u00a0\u00b5g\/mL. Wound-healing assays indicated changes in wound closure following KBP exposure. In addition, KBP treatment was associated with decreased expression of inflammation-related genes (\n                    <jats:italic>IL-6<\/jats:italic>\n                    ,\n                    <jats:italic>IL-10<\/jats:italic>\n                    ,\n                    <jats:italic>NFK\u03b2<\/jats:italic>\n                    , and\n                    <jats:italic>TNF-\u03b1<\/jats:italic>\n                    ) and increased expression of genes related to skin barrier\/keratinization (\n                    <jats:italic>IVL<\/jats:italic>\n                    and\n                    <jats:italic>FLG<\/jats:italic>\n                    ). The magnitude of these effects differed across cell types, indicating cell-specific responses. Further research is warranted to validate these findings in in vivo models and to clarify the potential applications of KBP in dermatological contexts.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-52512-9","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T09:24:02Z","timestamp":1779355442000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Investigation of the effects of a Kiperin Bromelain &amp; Papain complex in normal colon, mammary, and skin cells"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4803-9137","authenticated-orcid":false,"given":"Lutfiye Karcioglu","family":"Batur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuneyd","family":"Yavas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nezih","family":"Hekim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"key":"52512_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/life11040317","volume":"11","author":"AJ Chakraborty","year":"2021","unstructured":"Chakraborty, A. J. et al. Bromelain a potential bioactive compound: A comprehensive overview from a pharmacological perspective. Life 11, 317. https:\/\/doi.org\/10.3390\/life11040317 (2021).","journal-title":"Life"},{"key":"52512_CR2","doi-asserted-by":"publisher","first-page":"257","DOI":"10.30476\/dentjods.2021.89577.1478","volume":"23","author":"M Kiani","year":"2022","unstructured":"Kiani, M. et al. Anti-cancer effect of bromelain and its combination with cisplatin on HN5 cell line (squamous cell carcinoma)... J. Dent. 23, 257\u2013265. https:\/\/doi.org\/10.30476\/dentjods.2021.89577.1478 (2022).","journal-title":"J. Dent."},{"key":"52512_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1068778","volume":"12","author":"R Pezzani","year":"2023","unstructured":"Pezzani, R. et al. Anticancer properties of bromelain: State-of-the-art and recent trends. Front. Oncol. 12, 1068778. https:\/\/doi.org\/10.3389\/fonc.2022.1068778 (2023).","journal-title":"Front. Oncol."},{"key":"52512_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/foods10102249","volume":"10","author":"C Varilla","year":"2021","unstructured":"Varilla, C., Marcone, M., Paiva, L. & Baptista, J. Bromelain, a group of pineapple proteolytic complex enzymes (Ananas comosus) and their possible therapeutic and clinical effects. A summary. Foods 10, 2249. https:\/\/doi.org\/10.3390\/foods10102249 (2021).","journal-title":"Foods"},{"key":"52512_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/app15052637","volume":"15","author":"M Venetikidou","year":"2025","unstructured":"Venetikidou, M. et al. Proteolytic enzyme activities of bromelain, ficin, and papain from fruit by-products and potential applications in sustainable and functional cosmetics for skincare. Appl. Sci. 15, 2637. https:\/\/doi.org\/10.3390\/app15052637 (2025).","journal-title":"Appl. Sci."},{"key":"52512_CR6","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3892\/br.2016.720","volume":"5","author":"V Rathnavelu","year":"2016","unstructured":"Rathnavelu, V., Alitheen, N. B., Sohila, S., Kanagesan, S. & Ramesh, R. Potential role of bromelain in clinical and therapeutic applications. Biomed. Rep. 5, 283\u2013288. https:\/\/doi.org\/10.3892\/br.2016.720 (2016).","journal-title":"Biomed. Rep."},{"key":"52512_CR7","doi-asserted-by":"publisher","first-page":"551","DOI":"10.17221\/3012-vetmed","volume":"55","author":"P Siengdee","year":"2010","unstructured":"Siengdee, P. et al. Effects of bromelain on cellular characteristics and expression of selected genes in canine in vitro chondrocyte culture. Veter- Med. 55, 551\u2013560. https:\/\/doi.org\/10.17221\/3012-vetmed (2010).","journal-title":"Veter- Med."},{"issue":"3","key":"52512_CR8","first-page":"24","volume":"11","author":"AA Ausaj","year":"2024","unstructured":"Ausaj, A. A., Abed, W. B. & Al-Shmgani, H. S. The use of proteolytic enzymes in inhibiting cancer as anti-angiogenesis agents: Mechanisms of action. Opera Med. Physiol. 11(3), 24\u201331 (2024).","journal-title":"Opera Med. Physiol."},{"key":"52512_CR9","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/mnfr.201300345","volume":"58","author":"B Romano","year":"2013","unstructured":"Romano, B. et al. The chemopreventive action of bromelain, from pineapple stem (Ananas comosus L.), on colon carcinogenesis is related to antiproliferative and proapoptotic effects. Mol. Nutr. Food Res. 58, 457\u2013465. https:\/\/doi.org\/10.1002\/mnfr.201300345 (2013).","journal-title":"Mol. Nutr. Food Res."},{"key":"52512_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.34172\/jhp.2024.48078","volume":"13","author":"MR Khosravi","year":"2024","unstructured":"Khosravi, M. R., Raeisi, E., Heidari-Soureshjani, S. & Sherwin, C. M. The survey of antitumor effects of bromelain on neoplastic breast cells: A systematic review. J. Herbmed Pharmacol. 13, 10\u201318. https:\/\/doi.org\/10.34172\/jhp.2024.48078 (2024).","journal-title":"J. Herbmed Pharmacol."},{"key":"52512_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0210274","volume":"14","author":"T-C Chang","year":"2019","unstructured":"Chang, T.-C. et al. Bromelain inhibits the ability of colorectal cancer cells to proliferate via activation of ROS production and autophagy. PLoS ONE 14, e0210274. https:\/\/doi.org\/10.1371\/journal.pone.0210274 (2019).","journal-title":"PLoS ONE"},{"key":"52512_CR12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1080\/14728222.2023.2194531","volume":"27","author":"X Fei","year":"2023","unstructured":"Fei, X. et al. Papain exerts an anti-atherosclerosis effect with suppressed MPA-mediated foam cell formation by regulating the MAPK and PI3K\/Akt-NF-\u03baB pathways. Expert Opin. Ther. Targets 27, 239\u2013250. https:\/\/doi.org\/10.1080\/14728222.2023.2194531 (2023).","journal-title":"Expert Opin. Ther. Targets"},{"key":"52512_CR13","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/1472-6882-13-231","volume":"13","author":"T Mohr","year":"2013","unstructured":"Mohr, T. & Desser, L. Plant proteolytic enzyme papain abrogates angiogenic activation of human umbilical vein endothelial cells (HUVEC) in vitro. BMC Complement. Altern. Med. 13, 231\u2013231. https:\/\/doi.org\/10.1186\/1472-6882-13-231 (2013).","journal-title":"BMC Complement. Altern. Med."},{"key":"52512_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13020-016-0118-5","volume":"11","author":"AZM Pauzi","year":"2016","unstructured":"Pauzi, A. Z. M. et al. Combination of cisplatin and bromelain exerts synergistic cytotoxic effects against breast cancer cell line MDA-MB-231 in vitro. Chin. Med. 11, 1\u201311. https:\/\/doi.org\/10.1186\/s13020-016-0118-5 (2016).","journal-title":"Chin. Med."},{"key":"52512_CR15","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1002\/biof.121","volume":"36","author":"K Bhui","year":"2010","unstructured":"Bhui, K., Tyagi, S., Prakash, B. & Shukla, Y. Pineapple bromelain induces autophagy, facilitating apoptotic response in mammary carcinoma cells. BioFactors 36, 474\u2013482. https:\/\/doi.org\/10.1002\/biof.121 (2010).","journal-title":"BioFactors"},{"key":"52512_CR16","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.3892\/ijo.2016.3411","volume":"48","author":"A M\u00fcller","year":"2016","unstructured":"M\u00fcller, A. et al. Comparative study of antitumor effects of bromelain and papain in human cholangiocarcinoma cell lines. Int. J. Oncol. 48, 2025\u20132034. https:\/\/doi.org\/10.3892\/ijo.2016.3411 (2016).","journal-title":"Int. J. Oncol."},{"key":"52512_CR17","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1080\/14786419.2024.2342553","volume":"39","author":"TA Nobre","year":"2024","unstructured":"Nobre, T. A. et al. Bromelain as a natural anti-inflammatory drug: A systematic review. Nat. Prod. Res. 39, 1258\u20131271. https:\/\/doi.org\/10.1080\/14786419.2024.2342553 (2024).","journal-title":"Nat. Prod. Res."},{"key":"52512_CR18","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/btpr.2405","volume":"33","author":"N Luniak","year":"2016","unstructured":"Luniak, N., Meiser, P., Burkart, S. & M\u00fcller, R. Heterologous expression of the plant cysteine protease bromelain and its inhibitor in &lt;hi&gt;Pichia pastoris&lt;\/hi&gt;. Biotechnol. Prog. 33, 54\u201365. https:\/\/doi.org\/10.1002\/btpr.2405 (2016).","journal-title":"Biotechnol. Prog."},{"issue":"1","key":"52512_CR19","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3390\/antiox12010072","volume":"12","author":"CH Chen","year":"2022","unstructured":"Chen, C. H. et al. Bromelain ameliorates atherosclerosis by activating the TFEB-mediated autophagy and antioxidant pathways. Antioxidants (Basel) 12(1), 72 (2022).","journal-title":"Antioxidants (Basel)"},{"key":"52512_CR20","doi-asserted-by":"crossref","unstructured":"Amini, A., et al., Cytotoxic effects of bromelain in human gastrointestinal carcinoma cell lines (MKN45, KATO-III, HT29\u20135F12, and HT29\u20135M21). OncoTargets and therapy, 2013: p. 403\u2013409.","DOI":"10.2147\/OTT.S43072"},{"key":"52512_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25042110","volume":"25","author":"J Berfelde","year":"2024","unstructured":"Berfelde, J., Hildebrand, L. S., Kuhlmann, L., Fietkau, R. & Distel, L. V. FEN1 inhibition as a potential novel targeted therapy against breast cancer and the prognostic relevance of FEN1. Int. J. Mol. Sci. 25, 2110. https:\/\/doi.org\/10.3390\/ijms25042110 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"52512_CR22","doi-asserted-by":"publisher","first-page":"235","DOI":"10.26650\/iuitfd.1420664","volume":"87","author":"A Abua\u0131sha","year":"2019","unstructured":"Abua\u0131sha, A. et al. Effect of curcumin on breast cancer cells through miR-145-5p and its target genes. Eur. Oral Res. 87, 235\u2013245. https:\/\/doi.org\/10.26650\/iuitfd.1420664 (2019).","journal-title":"Eur. Oral Res."},{"key":"52512_CR23","doi-asserted-by":"publisher","first-page":"440","DOI":"10.4161\/cam.36224","volume":"8","author":"JEN Jonkman","year":"2014","unstructured":"Jonkman, J. E. N. et al. An introduction to the wound healing assay using live-cell microscopy. Cell Adhes. Migr. 8, 440\u2013451. https:\/\/doi.org\/10.4161\/cam.36224 (2014).","journal-title":"Cell Adhes. Migr."},{"issue":"6","key":"52512_CR24","doi-asserted-by":"publisher","first-page":"560","DOI":"10.3892\/ol.2025.15306","volume":"30","author":"LK Batur","year":"2025","unstructured":"Batur, L. K., Yavas, C. & Hekim, N. Anticancer effects of the Kiperin Purple Collagen complex: Evidence from HCT116 and MIA PaCa-2 cell models. Oncol. Lett. 30(6), 560 (2025).","journal-title":"Oncol. Lett."},{"issue":"1","key":"52512_CR25","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1186\/s12906-017-1962-2","volume":"17","author":"M Di Nunzio","year":"2017","unstructured":"Di Nunzio, M. et al. Is cytotoxicity a determinant of the different in vitro and in vivo effects of bioactives?. BMC Complement. Altern. Med. 17(1), 453 (2017).","journal-title":"BMC Complement. Altern. Med."},{"key":"52512_CR26","doi-asserted-by":"crossref","unstructured":"Batur, L. K., Yavas, C. & Polat, Y. Investigating the potential selective effects of a Kiperin multi-component magnesium supplement on colon cancer and normal cells. Sci. Rep. (2025).","DOI":"10.1038\/s41598-025-32854-6"},{"issue":"6","key":"52512_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13061430","volume":"13","author":"L Karcioglu Batur","year":"2025","unstructured":"Karcioglu Batur, L., Yavas, C., Ekeno\u011flu Merdan, Y. & Aygan, A. Kiperin postbiotic supplement-enhanced bacterial supernatants promote fibroblast function: Implications for regenerative medicine. Biomedicines 13(6), 1430 (2025).","journal-title":"Biomedicines"},{"issue":"5","key":"52512_CR28","doi-asserted-by":"publisher","first-page":"364","DOI":"10.3390\/cimb47050364","volume":"47","author":"L Karcioglu Batur","year":"2025","unstructured":"Karcioglu Batur, L., Yavas, C. & Hekim, N. Kiperin double-hydrolyzed collagen as a potential anti-tumor agent: Effects on HCT116 colon carcinoma cells and oxidative stress modulation. Curr. Issues Mol. Biol. 47(5), 364 (2025).","journal-title":"Curr. Issues Mol. Biol."},{"issue":"3","key":"52512_CR29","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.envpol.2004.10.001","volume":"138","author":"EJ Calabrese","year":"2005","unstructured":"Calabrese, E. J. Paradigm lost, paradigm found: The re-emergence of hormesis as a fundamental dose response model in the toxicological sciences. Environ. Pollut. 138(3), 378\u2013411 (2005).","journal-title":"Environ. Pollut."},{"key":"52512_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-89376-0","volume":"11","author":"JA Ataide","year":"2021","unstructured":"Ataide, J. A. et al. In vitro performance of free and encapsulated bromelain. Sci. Rep. 11, 1\u201310. https:\/\/doi.org\/10.1038\/s41598-021-89376-0 (2021).","journal-title":"Sci. Rep."},{"key":"52512_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.adcanc.2021.100025","volume":"4","author":"A Anilkumar","year":"2022","unstructured":"Anilkumar, A. & Bhanu, A. In vitro anticancer activity of \u201cMethanolic extract of papaya blackseeds\u201d(MPB) in Hep G2 cell lines and its effect in the regulation of bcl-2, caspase-3 and p53 gene expression. Adv. Cancer Biol. Metastasis 4, 100025 (2022).","journal-title":"Adv. Cancer Biol. Metastasis"},{"key":"52512_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17050606","volume":"17","author":"KB Narayanan","year":"2025","unstructured":"Narayanan, K. B. Enzyme-based anti-inflammatory therapeutics for inflammatory diseases. Pharmaceutics 17, 606. https:\/\/doi.org\/10.3390\/pharmaceutics17050606 (2025).","journal-title":"Pharmaceutics"},{"key":"52512_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26178347","volume":"26","author":"Y Sethia","year":"2025","unstructured":"Sethia, Y., Polak-Szczyby\u0142o, E. & Tabarkiewicz, J. Bromelain in obesity therapy: A review of anti-inflammatory and metabolic mechanisms. Int. J. Mol. Sci. 26, 8347. https:\/\/doi.org\/10.3390\/ijms26178347 (2025).","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"52512_CR34","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/j.jcmgh.2021.07.005","volume":"12","author":"HD Nguyen","year":"2021","unstructured":"Nguyen, H. D., Aljamaei, H. M. & Stadnyk, A. W. The production and function of endogenous interleu-kin-10 in intestinal epithelial cells and gut homeostasis. Cell. Mol. Gastroenterol. Hepatol. 12(4), 1343\u20131352 (2021).","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"52512_CR35","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1093\/intimm\/12.2.133","volume":"12","author":"TL Denning","year":"2000","unstructured":"Denning, T. L. et al. Expression of IL-10 receptors on epithelial cells from the murine small and large intestine. Int. Immunol. 12, 133\u2013139. https:\/\/doi.org\/10.1093\/intimm\/12.2.133 (2000).","journal-title":"Int. Immunol."},{"key":"52512_CR36","doi-asserted-by":"publisher","first-page":"122","DOI":"10.5021\/ad.2020.32.2.122","volume":"32","author":"J Lee","year":"2020","unstructured":"Lee, J., Jang, A., Seo, S. J. & Myung, S. C. Epigenetic regulation of filaggrin gene expression in human epidermal keratinocytes. Ann. Dermatol. 32, 122\u2013129. https:\/\/doi.org\/10.5021\/ad.2020.32.2.122 (2020).","journal-title":"Ann. Dermatol."},{"issue":"10","key":"52512_CR37","first-page":"16","volume":"6","author":"J Levin","year":"2013","unstructured":"Levin, J., Friedlander, S. F. & Del Rosso, J. Q. Atopic dermatitis and the stratum corneum: Part 1: The role of filaggrin in the stratum corneum barrier and atopic skin. J. Clin. Aesthet. Dermatol. 6(10), 16 (2013).","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"52512_CR38","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jds.2022.09.018","volume":"18","author":"H-C Lu","year":"2022","unstructured":"Lu, H.-C. et al. Bromelain inhibits the inflammation and senescence effect in diabetic periodontitis: A preliminary in vitro study. J. Dent. Sci. 18, 659\u2013665. https:\/\/doi.org\/10.1016\/j.jds.2022.09.018 (2022).","journal-title":"J. Dent. Sci."},{"key":"52512_CR39","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s12272-021-01305-x","volume":"44","author":"Y Kim","year":"2021","unstructured":"Kim, Y. & Lim, K.-M. Skin barrier dysfunction and filaggrin. Arch. Pharmacal Res. 44, 36\u201348. https:\/\/doi.org\/10.1007\/s12272-021-01305-x (2021).","journal-title":"Arch. Pharmacal Res."},{"key":"52512_CR40","doi-asserted-by":"publisher","first-page":"E78","DOI":"10.1111\/1346-8138.15736","volume":"48","author":"K Teye","year":"2020","unstructured":"Teye, K. et al. Filaggrin gene (FLG) promoter polymorphisms are associated with atopic dermatitis in the Japanese population. J. Dermatol. 48, E78\u2013E79. https:\/\/doi.org\/10.1111\/1346-8138.15736 (2020).","journal-title":"J. Dermatol."},{"key":"52512_CR41","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1111\/bjd.12206","volume":"168","author":"M Li","year":"2013","unstructured":"Li, M. et al. Analyses ofFLGmutation frequency and filaggrin expression in isolated ichthyosis vulgaris (IV) and atopic dermatitis-associated IV. Br. J. Dermatol. 168, 1335\u20131338. https:\/\/doi.org\/10.1111\/bjd.12206 (2013).","journal-title":"Br. J. Dermatol."},{"key":"52512_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19061654","volume":"19","author":"A Hashimoto-Hachiya","year":"2018","unstructured":"Hashimoto-Hachiya, A., Tsuji, G., Murai, M., Yan, X. & Furue, M. Upregulation of FLG, LOR, and IVL expression by Rhodiola crenulata root extract via aryl hydrocarbon receptor: Differential involvement of OVOL1. Int. J. Mol. Sci. 19, 1654. https:\/\/doi.org\/10.3390\/ijms19061654 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"52512_CR43","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/j.1600-0897.2011.00989.x","volume":"66","author":"A Braunschweig","year":"2011","unstructured":"Braunschweig, A., Poehlmann, T. G., Busch, S., Schleussner, E. & Markert, U. R. Signal transducer and activator of transcription 3 (STAT3) and suppressor of cytokine signaling (SOCS3) balance controls cytotoxicity and IL-10 expression in decidual-like natural killer cell line NK-92. Am. J. Reprod. Immunol. 66, 329\u2013335. https:\/\/doi.org\/10.1111\/j.1600-0897.2011.00989.x (2011).","journal-title":"Am. J. Reprod. Immunol."},{"key":"52512_CR44","first-page":"157","volume":"380","author":"L Gabrysova","year":"2014","unstructured":"Gabrysova, L. et al. The regulation of IL-10 expression. Curr Top Microbiol Immunol 380, 157\u2013190 (2014).","journal-title":"Curr Top Microbiol Immunol"},{"key":"52512_CR45","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.2174\/0115680266277952240223120435","volume":"24","author":"NS Kumar","year":"2024","unstructured":"Kumar, N. S., Reddy, N., Kumar, H. & Vemireddy, S. Immunomodulatory plant natural products as therapeutics against inflammatory skin diseases. Curr. Top. Med. Chem. 24, 1013\u20131034. https:\/\/doi.org\/10.2174\/0115680266277952240223120435 (2024).","journal-title":"Curr. Top. Med. Chem."},{"key":"52512_CR46","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.2174\/0929867322666150227151809","volume":"22","author":"R Tundis","year":"2015","unstructured":"Tundis, R., Loizzo, M. R., Bonesi, M. & Menichini, F. Potential role of natural compounds against skin aging. Curr. Med. Chem. 22, 1515\u20131538. https:\/\/doi.org\/10.2174\/0929867322666150227151809 (2015).","journal-title":"Curr. Med. Chem."},{"key":"52512_CR47","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1021\/acsomega.3c08463","volume":"9","author":"A Haque","year":"2023","unstructured":"Haque, A. et al. Synthesis, characterization, antiglycation evaluation, molecular docking, and ADMET studies of 4-thiazolidinone derivatives. ACS Omega 9, 1810\u20131820. https:\/\/doi.org\/10.1021\/acsomega.3c08463 (2023).","journal-title":"ACS Omega"},{"issue":"4","key":"52512_CR48","first-page":"1","volume":"7","author":"Z Marrisa","year":"2024","unstructured":"Marrisa, Z. et al. Exploring the potential use of bromelain in cosmeceuticals: A review. J. Appl. Pharm. Sci. Res. 7(4), 1\u20137 (2024).","journal-title":"J. Appl. Pharm. Sci. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52512-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52512-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52512-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T11:02:45Z","timestamp":1787742165000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52512-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["52512"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-52512-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"assertion":[{"value":"29 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"L.K.B. serves as a scientific consultant for Kiperin Pharmaceutical Food Industry and Trade Limited Company (Istanbul, Turkiye). This relationship has been disclosed in the interest of transparency. However, the study was conducted independently, and the company had no role in the study design, data collection, data analysis, interpretation of the data, writing of the manuscript, or decision to publish the results. To further ensure scientific rigor and reduce the risk of bias, statistical analyses were performed by an independent researcher with no affiliation to the company. C.Y. declares no conflicts of interest.","order":1,"name":"Ethics","label":"Competing Interest","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The study protocol received ethical approval from the Scientific Research Ethics Committee of Biruni University on July 28, 2025 (Approval No: 2024-BIAEK\/12-23), confirming adherence to ethical research principles.","order":2,"name":"Ethics","label":"Institutional review board statement","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Not applicable, as this study did not include human subjects or pa-tient-related data.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"26713"}}